SFEBES2019Satellite

All speakers
Pituitary: The New & the Old
Panel Discussion and Q&A
Session starts at 12:45 11-Nov

Dr Alia Munir
Neuroendocrine tumours for the general endocrinologist
GEP-NETs and PRRT
Session starts at 12:45 11-Nov

Dr Anna Olsson-Brown and Dr Claire Higham
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
Examples from the clinic and Q&A
Session starts at 13:20 13-Nov

Dr Anna Olsson-Brown and Dr Claire Higham
Immunotherapy-related endocrinopathies during cancer treatment: Conquering the hidden threat
The cancer treatment landscape: Current status of immunotherapies and a practical guide to immune-related endocrinopathies
Session starts at 13:20 13-Nov

Joan Grieve
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
From the first step: Designing management strategies for the future
Session starts at 13:35 12-Nov

John Newell-Price
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Getting it right first time: Harnessing experience and expertise to improve outcomes
Session starts at 13:35 12-Nov

John Wass
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Starting a movement in Cushing’s syndrome
Session starts at 13:35 12-Nov

John Wass (Oxford, UK) and faculty
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
Collective thinking: How we can build Cushing’s syndrome management strategies with confidence
Session starts at 13:35 12-Nov

Menai Owen-Jones
Collective thinking: Can greater collaboration improve outcomes in Cushing’s syndrome?
The patient journey in Cushing’s syndrome: Can we change the route to a new destination?
Session starts at 13:35 12-Nov

Niki Karavitaki
Pituitary: The New & the Old
Nelson’s syndrome
Session starts at 12:45 11-Nov

Professor AJ van der Lely
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
A brief history of ACROSTUDY
Session starts at 13:35 12-Nov

Professor Ashley Grossman
Neuroendocrine tumours for the general endocrinologist
Welcome & Introduction
Session starts at 12:45 11-Nov

Professor Maralyn Druce
Neuroendocrine tumours for the general endocrinologist
Overview & management of NETS
Session starts at 12:45 11-Nov

Professor Richard Ross
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Key outcomes: exploring safety and treatment outcomes
Session starts at 13:35 12-Nov

Professor Richard Ross
ACROSTUDY™: Over a decade of real world data recording the treatment of acromegaly with pegvisomant – what have we learned?
Impact of treatment on glucose metabolism
Session starts at 13:35 12-Nov

Robert Murray
Pituitary: The New & the Old
Checkpoint inhibitor related hypophysitis
Session starts at 12:45 11-Nov

Speaker TBC
Pituitary: The New & the Old
BRAF inhibitors in Papillary Craniopharyngiomas
Session starts at 12:45 11-Nov